(INT) Intellego Technologies - Ratings and Ratios
UV Indicator Patch, UV Dose Card, Skin Sun Monitor
INT EPS (Earnings per Share)
INT Revenue
Description: INT Intellego Technologies
Intellego Technologies AB is a Swedish company that specializes in manufacturing and selling colorimetric ultraviolet (UV) indicators. Their product portfolio includes the UVC Dosimeter, a photochromic indicator that changes color in response to accumulated UV-C irradiation, and SmartSun Bands, which help individuals monitor their sun exposure to prevent sunburn and skin damage. These products cater to various industries, including healthcare, hospitality, and retail.
To evaluate Intellego Technologies performance, we can examine key performance indicators (KPIs) such as revenue growth, market share, and customer acquisition costs. With a market capitalization of 3658.84M SEK and a return on equity (RoE) of 45.44%, the company demonstrates a strong financial position. The price-to-earnings (P/E) ratio of 28.41 suggests that the stock is moderately valued relative to its earnings. Additionally, the companys ability to generate revenue from diverse industries and its expanding product portfolio are positive indicators of its growth potential.
From a technical analysis perspective, Intellego Technologies stock has shown a strong upward trend, with the short-term (SMA20) and long-term (SMA200) moving averages indicating a significant increase in stock price over time. The average true range (ATR) of 7.90 (5.99%) suggests moderate volatility, which may be attractive to some investors. To further assess the stocks potential, we can examine other KPIs such as the relative strength index (RSI), Bollinger Bands, and trading volume to gauge market sentiment and potential price movements.
To make informed investment decisions, it is essential to analyze Intellego Technologies financial statements, industry trends, and competitive landscape. By examining the companys revenue streams, profit margins, and cash flow generation, we can better understand its financial health and growth prospects. Furthermore, assessing the competitive landscape and industry trends can help identify potential opportunities and challenges that may impact Intellego Technologies future performance.
INT Stock Overview
| Market Cap in USD | 471m |
| Sub-Industry | Electrical Components & Equipment |
| IPO / Inception |
INT Stock Ratings
| Growth Rating | 95.3% |
| Fundamental | 81.3% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 560% |
| Analyst Rating | - |
INT Dividends
Currently no dividends paidINT Growth Ratios
| Growth Correlation 3m | 92.6% |
| Growth Correlation 12m | 94.1% |
| Growth Correlation 5y | 85.4% |
| CAGR 5y | 152.70% |
| CAGR/Max DD 5y | 2.34 |
| Sharpe Ratio 12m | -0.05 |
| Alpha | 654.06 |
| Beta | 0.299 |
| Volatility | 69.62% |
| Current Volume | 1131.1k |
| Average Volume 20d | 301k |
| Stop Loss | 195.5 (-4.6%) |
| Signal | 2.97 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (441.9m TTM) > 0 and > 6% of Revenue (6% = 272.4m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA 9.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.45% (prev 42.42%; Δ -36.97pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 7.81 (>3.0%) and CFO 4.13b > Net Income 441.9m (YES >=105%, WARN >=100%) |
| Net Debt (38.3m) to EBITDA (192.1m) ratio: 0.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.48 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.7m) change vs 12m ago 10.58% (target <= -2.0% for YES) |
| Gross Margin 98.43% (prev 75.92%; Δ 22.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1076 % (prev 73.88%; Δ 1002 pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.52 (EBITDA TTM 192.1m / Interest Expense TTM 334.3m) >= 6 (WARN >= 3) |
Altman Z'' 8.42
| (A) 0.47 = (Total Current Assets 347.4m - Total Current Liabilities 99.9m) / Total Assets 528.3m |
| (B) 0.36 = Retained Earnings (Balance) 192.8m / Total Assets 528.3m |
| (C) 0.41 = EBIT TTM 174.7m / Avg Total Assets 421.9m |
| (D) 1.31 = Book Value of Equity 193.9m / Total Liabilities 148.1m |
| Total Rating: 8.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 81.33
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield -0.74% = -0.37 |
| 3. FCF Margin -0.73% = -0.28 |
| 4. Debt/Equity 0.09 = 2.50 |
| 5. Debt/Ebitda 0.18 = 2.47 |
| 6. ROIC - WACC 41.42% = 12.50 |
| 7. RoE 153.2% = 2.50 |
| 8. Rev. Trend 74.77% = 3.74 |
| 9. Rev. CAGR 576.5% = 2.50 |
| 10. EPS Trend 70.60% = 1.76 |
| 11. EPS CAGR 277.7% = 2.50 |
What is the price of INT shares?
Over the past week, the price has changed by +32.26%, over one month by +61.42%, over three months by +147.88% and over the past year by +672.13%.
Is Intellego Technologies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INT is around 256.87 SEK . This means that INT is currently undervalued and has a potential upside of +25.3% (Margin of Safety).
Is INT a buy, sell or hold?
What are the forecasts/targets for the INT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 170 | -17.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 282.9 | 38% |
INT Fundamental Data Overview
Market Cap SEK = 4.49b (4.49b SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 3.80m SEK (Cash And Short Term Investments, last quarter)
P/E Trailing = 34.8268
P/S = 11.5036
P/B = 11.437
Beta = 1.319
Revenue TTM = 4.54b SEK
EBIT TTM = 174.7m SEK
EBITDA TTM = 192.1m SEK
Long Term Debt = 19.0m SEK (from longTermDebt, last quarter)
Short Term Debt = 16.5m SEK (from shortTermDebt, last quarter)
Debt = 35.5m SEK (Calculated: Short Term 16.5m + Long Term 19.0m)
Net Debt = 38.3m SEK (from netDebt column, last quarter)
Enterprise Value = 4.52b SEK (4.49b + Debt 35.5m - CCE 3.80m)
Interest Coverage Ratio = 0.52 (Ebit TTM 174.7m / Interest Expense TTM 334.3m)
FCF Yield = -0.74% (FCF TTM -33.4m / Enterprise Value 4.52b)
FCF Margin = -0.73% (FCF TTM -33.4m / Revenue TTM 4.54b)
Net Margin = 9.73% (Net Income TTM 441.9m / Revenue TTM 4.54b)
Gross Margin = 98.43% ((Revenue TTM 4.54b - Cost of Revenue TTM 71.4m) / Revenue TTM)
Tobins Q-Ratio = 23.30 (Enterprise Value 4.52b / Book Value Of Equity 193.9m)
Interest Expense / Debt = 501.9% (Interest Expense 178.0m / Debt 35.5m)
Taxrate = 23.76% (from yearly Income Tax Expense: 22.5m / 94.8m)
NOPAT = 133.2m (EBIT 174.7m * (1 - 23.76%))
Current Ratio = 3.48 (Total Current Assets 347.4m / Total Current Liabilities 99.9m)
Debt / Equity = 0.09 (Debt 35.5m / last Quarter total Stockholder Equity 380.3m)
Debt / EBITDA = 0.18 (Net Debt 38.3m / EBITDA 192.1m)
Debt / FCF = -1.06 (Debt 35.5m / FCF TTM -33.4m)
Total Stockholder Equity = 288.5m (last 4 quarters mean)
RoA = 83.64% (Net Income 441.9m, Total Assets 528.3m )
RoE = 153.2% (Net Income TTM 441.9m / Total Stockholder Equity 288.5m)
RoCE = 56.82% (Ebit 174.7m / (Equity 288.5m + L.T.Debt 19.0m))
RoIC = 41.42% (NOPAT 133.2m / Invested Capital 321.5m)
WACC = unknown (E(4.49b)/V(4.52b) * Re(7.12%)) + (D(35.5m)/V(4.52b) * Rd(none%) * (1-Tc(0.24)))
Shares Correlation 5-Years: 100.0 | Cagr: 14.40%
Discount Rate = 7.12% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -33.4m)
Revenue Correlation: 74.77 | Revenue CAGR: 576.5%
Rev Growth-of-Growth: 40.77
EPS Correlation: 70.60 | EPS CAGR: 277.7%
EPS Growth-of-Growth: -132.3